Compare Exelixis Inc. Common Stock (EXEL) vs Northrop Grumman Corporation (NOC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Exelixis Inc. Common Stock vs Northrop Grumman Corporation — how do they compare? Exelixis Inc. Common Stock trades at $59.86 (market cap $14.62B), while Northrop Grumman Corporation trades at $480.72 (market cap $68.83B). The key difference: Northrop Grumman Corporation is far larger — about 4.7× Exelixis Inc. Common Stock's market cap, and Northrop Grumman Corporation pays a 2.04% dividend while Exelixis Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 1 Days and Northrop Grumman Corporation for 81 Days on average.
| EXEL | NOC | |
|---|---|---|
Market Cap | $14.62B | $68.83B |
Volume | 2,684,957 | 1,081,989 |
Sector | Health | Industrials |
52-Week High | $59.86 | $768.02 |
52-Week Low | $34.54 | $473.46 |
Typical Hold Time | 1 Days | 81 Days |
Enterprise Value | $13.95B | $82.81B |
Dividend Yield | — | 2.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Northrop Grumman (NOC) trades at $484.48, up 2.33% today, but technical indicators signal a bearish trend with the stock below key moving averages. Fundamentally, the company shows strength with a P/E of 15.4, robust profitability margins, and consistent earnings beats in recent quarters. Recent news highlights a mixed environment, including a significant contract loss to Boeing but sustained demand from defense budgets and a record backlog supporting future revenue.
The outlook remains positive due to strong fundamentals and analyst consensus, with a price target of $600.62 implying substantial upside. Key risks include competitive pressures from recent contract losses and dependence on government spending, but the company's financial health and dividend payments provide stability for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Exelixis Inc. Common Stock
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →About Northrop Grumman Corporation
Northrop Grumman is a defense contractor that is diversified across short-cycle and long-cycle businesses. The firm's segments include aeronautics, mission systems, defense services, and space systems. The company's aerospace segment creates the fuselage for the massive F-35 program and produces various piloted and autonomous flight systems. Mission systems creates a variety of sensors and processors for defense hardware. The defense systems segment is a long-range missile manufacturer. Finally, the company's space systems segment produces various space structures, sensors, and satellites.
Read more on NOC →
